
Dr. Vandana Gupta Abramson MD
Oncologist | Medical Oncology
2220 Pierce Ave 777 Preston Research Nashville TN, 37232About
Dr. Vandana Abramson is an oncologist practicing in Nashville, TN. Dr. Abramson specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Abramson manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 2006
Internal MedicineAmerican Board of Internal MedicineABIM- 2005
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is
- Clinical utility of serum tumor markers and circulating tumor cell assays in the treatment of breast cancer.
- Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer.
- Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy.
- Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms.
- Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report.
- Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to
- Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.
- New strategies for triple-negative breast cancer--deciphering the heterogeneity.
- Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.
- Longitudinal, intermodality registration of quantitative breast PET and MRI data acquired before and during neoadjuvant chemotherapy: preliminary results.
- Molecular Heterogeneity of Triple Negative Breast Cancer.
- Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy.
- Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer.
- Analysis of Risk of Recurrence by Subtype in ≤ 1-cm Breast Tumors.
Clinical Trials
Treatments
- Breast Cancer
Fellowships
- University of Pennsylvania 2006
Dr. Vandana Gupta Abramson MD's Practice location
Vandana Abramson
2220 Pierce Ave 777 Preston Research -Nashville, TN 37232Get Direction
Dr. Vandana Gupta Abramson MD's reviews
Write ReviewPatient Experience with Dr. Abramson
Recommended Articles
- Cholesterol Drugs Could Treat Ovarian Cancer, New Research Suggests
What are statins?Statins are medications that are commonly used to treat low-density lipoprotein cholesterol levels in the blood. LDL cholesterol is commonly known as “bad cholesterol” and statins help to reduce its production inside the liver. More than 30% of Americans have high levels of LDL...
- Is Recovery from Stage IV Ovarian Cancer Possible?
Ovarian cancer is a struggle many people have faced, whether you are the one who has it, you know someone who has it, or you already kicked its butt. Cancer is not only a tough situation for the diagnosed, but it is often painful for the family and friends of the afflicted. The way one deals with...
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
- She Survived Breast Cancer, But Says a Treatment Side Effect Almost Killed Her
In 2014, 47-year-old Virginia Harrod found a lump in her breast, which was actually stage III breast cancer. She was immediately started on shock-and-awe chemotherapy, but as it turned out, the cancer was chemo-resistant and the tumor only grew with each treatment. Harrod then underwent a double...
- Breast Cancer: Why it's Absolutely Essential for Men to get Checked, too
Breast cancer draws a lot of publicity and attention, and when many think of breast cancer, they are likely thinking of women. This makes sense because “breast” is typically a female word, and every year there are tons of breast cancer awareness campaigns that revolve around women and are...
- Ovarian Cancer Vaccine Development: An Update
OncBioMune Pharmaceuticals, a clinical-stage bio-pharmaceutical company, is advancing its developments in vaccine technology to help boost the immune system to target cancer cells without causing harm to the patient. They have worked on prostate cancer vaccines and are working on ovarian cancer...
Nearby Providers
- Dr. Johann Brandes MD, PHD2306 Hampton Avenue Nashville Tennessee 37215
- Dr. Pat Whitworth MD2004 Hayes St Nashville TN 37203
- Dr. Deborah Lehrich MD730 Cool Springs Blvd Franklin TN 37067
- Dr. Nancy Davis MD3601 THE VANDERBILT CLINIC NASHVILLE TN 37232
- Dr. David Chism MD3601 THE VANDERBILT CLINIC NASHVILLE TN 37232
- Dr. Michel E Kuzur MD3443 Dickerson Pike Nashville TN 37207
Nearest Hospitals
SAINT THOMAS MIDTOWN HOSPITALl
2000 CHURCH ST NASHVILLE TN 37236SAINT THOMAS MIDTOWN HOSPITALl
2000 CHURCH ST NASHVILLE TN 37236